Vaxxinity, Inc.
EA Therapies for Single Patient

Currently, Vaxxinity has no products available via single-patient EA.

EA Policies for Single Patient

Vaxxinity is committed to developing safe and effective immunotherapeutic vaccines, with a goal of providing our next generation products as soon as possible through efficient product development. At this time, Vaxxinity’s investigational products can only be accessed through participation in a clinical trial. Vaxxinity does not currently offer an expanded access program.